Ads
related to: dulera inhaler generic name- Adverse Reactions
Learn About The Adverse Reactions
Of This Daily Asthma Treatment.
- Dosing Information
HCPs: See The Dosing Information Of
This Once-Daily Asthma Inhaler.
- Formulary Coverage
See If Your Patients Are Covered
With This Daily Asthma Treatment.
- Samples & Savings
Request Samples For Your Practice
Daily Triple Therapy Asthma Option.
- Adverse Reactions
Search results
Results From The WOW.Com Content Network
Mometasone/formoterol, sold under the brand name Dulera among others, is a fixed-dose combination medication used in the long-term treatment of asthma. [1] It contains mometasone a steroid and formoterol a long-acting beta agonist. [1] It is only recommended in those for whom an inhaled steroid is not sufficient. [1] It is used by inhalation. [1]
Studies have demonstrated the safety of inhaled fluticasone propionate in children. A systematic review published in 2013 found no significant adverse effect on the function of the hypothalamic–pituitary–adrenal axis , growth, and bone mineral density in asthmatic children when inhaled fluticasone is used for up to three months.
Budesonide/formoterol, sold under the brand name Symbicort among others, is a fixed-dose combination medication used in the management of asthma or chronic obstructive pulmonary disease (COPD). [2] It contains budesonide, a steroid; and formoterol, a long-acting β 2-agonist (LABA). [2]
Inhalant – non-medical drugs administered via inhalation This page was last edited on 24 March 2024, at 03:54 (UTC). Text is available under the Creative Commons ...
Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim.
As of December 2015, fluticasone furoate/vilanterol inhalation powder was approved for marketing in 73 countries, and had been launched in 45 countries. [13] Within the brand name, the Ellipta is the dry powder inhaler that the medication is administered in. Innoviva developed the active substance vilanterol, and receives royalties on sales. [14]